Vimarsana
Biggest News Aggregation in the World

Valency Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valency Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valency Communications Today - Breaking & Trending Today

20Med Therapeutics Appoints Industry Veteran Hugo Fry as - Vimarsana News

20Med Therapeutics Appoints Industry Veteran Hugo Fry as

Leiden, The Netherlands, November 29, 2023 – 20Med Therapeutics, a leader in non-viral delivery of mRNA vaccines, today announced the appointment of Hugo...

Mendus will participate in multiple investor and industry conferences in October and announces presentation of ALISON trial update at SITC - Vimarsana News

Mendus will participate in multiple investor and industry conferences in October and announces presentation of ALISON trial update at SITC

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: LSX...

Mendus to present novel data supporting the broad potential of its proprietary cancer vaccine platform at CICON23 - Vimarsana News

Mendus to present novel data supporting the broad potential of its proprietary cancer vaccine platform at CICON23

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will present novel clinical and preclinical data on the mode of action of its lead clinical program...

Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia (AML) - Vimarsana News

Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia (AML)

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that it has received Fast Track Designation from the U.S. Food and Drug Administration ...

Mendus Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference in September - Vimarsana News

Mendus Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference in September

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company will present a company presentation and participate in one-on-one...